Sequence-constructive SELEX: A new strategy for screening DNA aptamer binding to Globo H. Biochem Biophys Res Commun. 2014;452:484-489. [PMID: 25159850 DOI: 10.1016/j.bbrc.2014.08.086]

Efficient Screening of Glycan-Specific Aptamers Using a Glycosylated Peptide as a Scaffold

Abnormal glycan structures are valuable biomarkers for disease states; the development of glycan-specific binders is thereby significantly important. However, the structural homology and weak immunogenicity of glycans pose major hurdles in the evolution of antibodies, while the poor availability of complex glycans also has extremely hindered the selection of anti-glycan aptamers. Herein, we present a new approach to efficiently screen aptamers toward specific glycans with a complex structure, using a glycosylated peptide as a scaffold. In this method, using peptide-imprinted magnetic nanoparticles (MNPs) as a versatile platform, a glycopeptide tryptically digested from a native glycoprotein was selectively entrapped for positive selection, while a nonglycosylated analogue with an identical peptide sequence was synthesized for negative selection. Alternating positive and negative selection steps were carried out to guide the directed evolution of glycan-binding aptamers. As proof of the principle, the biantennary digalactosylated disialylated N-glycan A2G2S2, against which there have been no antibodies and lectins so far, was employed as the target. With the glycoprotein transferrin as a source of target glycan, two satisfied anti-A2G2S2 aptamers were selected within seven rounds. Since A2G2S2 is upregulated in cancerous liver cells, carboxyfluorescein (FAM)-labeled aptamers were prepared as fluorescent imaging reagents, and successful differentiation of cancerous liver cells over normal liver cells was achieved, which demonstrated the application feasibility of the selected aptamers. This approach obviated a tedious glycan preparation process and allowed favorable expose of the intrinsic flexible conformation of natural glycans. Therefore, it holds great promise for developing glycan-specific aptamers for challenging applications such as cancer targeting.

Targeting Oligosaccharides and Glycoconjugates Using Superselective Binding Scaffolds

Recognition of oligosaccharides is associated with very limited specificity due to their strong solvation in water and the high degree of subtle structural variations between them. Here, oligosaccharide recognition sites are created on material surfaces with unmatched, binary on-off binding behavior, sharply discriminating a target oligosaccharide over closely related carbohydrate structures. The basis for the superselective binding behavior relies on the highly efficient generation of a pure, high order complex of the oligosaccharide target with synthetic carbohydrate receptor sites, in which the spatial arrangement of the multiple receptors in the complex is preserved upon material surface incorporation. The synthetic binding scaffolds can easily be tailored to recognize different oligosaccharides and glycoconjugates, opening up a realm of possibilities for their use in a wide field of applications, ranging from life sciences to diagnostics.

The challenges of glycan recognition with natural and artificial receptors

Glycans - simple or complex carbohydrates - play key roles as recognition determinants and modulators of numerous physiological and pathological processes. Thus, many biotechnological, diagnostic and therapeutic opportunities abound for molecular recognition entities that can bind glycans with high selectivity and affinity. This review begins with an overview of the current biologically and synthetically derived glycan-binding scaffolds that include antibodies, lectins, aptamers and boronic acid-based entities. It is followed by a more detailed discussion on various aspects of their generation, structure and recognition properties. It serves as the basis for highlighting recent key developments and technical challenges that must be overcome in order to fully deal with the specific recognition of a highly diverse and complex range of glycan structures.

Super-resolution imaging of cancer-associated carbohydrates using aptamer probes

Globo H, as one of the most crucial cancer-associated carbohydrates, is exclusively overexpressed in a variety of cancers. However, the accurate localization and detailed morphology of globo H at the molecular level remain unclear. Here, we applied direct stochastic optical reconstruction microscopy (dSTORM) and relied on fluorophore-conjugated aptamers to solve the problem. The results showed that globo H organized as clusters on cell membranes with irregular shapes and different sizes from 100 to 300 nm. Significantly, globo H was found to have a higher expression level and larger clusters on various cancer cells than on non-cancer cells, which hinted that its specific distribution could be utilized for cancer diagnosis. Moreover, dual-color dSTORM imaging revealed the colocalization of globo H and other cancer-associated carbohydrates, and the clustering of globo H could be disrupted by the treatment of corresponding glycosidases, which indicated that these carbohydrates might intertwine in spatial organization and function cooperatively in cancers. Our work clarified the clustered distribution of globo H at the nanometer scale and revealed the potential interactions between cancer-associated carbohydrates, which paves the way for further understanding the relationship between the spatial structures and functions of carbohydrates in cancers.

Screening of aptamers and their potential application in targeted diagnosis and therapy of liver cancer

Aptamers are a class of single oligonucleotide molecules (DNA or RNA) that are screened from random DNA or RNA oligonucleotide chain libraries by the systemic evolution of ligands by exponential enrichment technology. The selected aptamers are capable of specifically binding to different targeting molecules, which is achieved by the three-dimensional structure of aptamers. Aptamers are similar in function to monoclonal antibodies, and therefore, they are also referred to as "chemical antibodies". Due to their high affinity and specificity and low immunogenicity, aptamers are topics of intense interest in today's biological targeting research especially in tumor research. They not only have high potential for clinical advances in tumor targeting detection but also are highly promising as targeted tumor drug carriers for use in tumor therapy. Various experimental studies have shown that aptamer-based diagnostic and therapeutic methods for liver cancer have great potential for application. This paper summarizes the structure, characteristics, and screening methods of aptamers and reviews the recent research progress on nucleic acid aptamers in the targeted diagnosis and treatment of liver cancer.

The registration of aptamer-ligand (ochratoxin A) interactions based on ligand fluorescence changes

The fluorescent properties of ligands can change when they bind to specific receptors. Modulated by the transition of the ligand from the free to the bound state, fluorescence makes it possible both to detect this ligand and quantitatively register its binding. We characterized the interaction of ochratoxin A (OTA) with the specific G-quadruplex aptamer through excitation-emission matrix fluorescence spectroscopy. It was shown that the formation of the complex changes the OTA fluorescence spectrum both in the region of the main peak at λ_ex/λ_em 380/430 nm and in the region of peak at λ_ex/λ_em 265/425 nm. At pH 8.5 and OTA concentration of 30 nM, this peak is smaller in intensity than the main peak of fluorescence. The formation of the complex with the aptamer leads to an increase of the fluorescence at λ_ex/λ_em 265/425 nm up to 6.5 times, which makes it up to 4.9 times more intense than fluorescence at 380/430 nm. Fluorescence of the G-quadruplex aptamer (donor) takes part in increasing of the OTA (acceptor) emission at λ_ex/λ_em 265/425 nm due to the resonance energy transfer. The concentration regularities of the modulated fluorescence of OTA at λ_ex/λ_em 265/425 nm have been studied. Their correspondence to the calculations of complexation conducted on the basis of the dissociation constant is shown.

Aptamer-recognized carbohydrates on the cell membrane revealed by super-resolution microscopy

Carbohydrates are one of the most important components on the cell membrane, which participate in various physiological activities, and their aberrant expression is a consequence of pathological changes. In previous studies, carbohydrate analysis basically relied on lectins. However, discrimination between lectins still exists due to their multivalent character. Furthermore, the structures obtained by carbohydrate-lectin crosslinking confuse our direct observation to some extent. Fortunately, the emergence of aptamers, which are smaller and more flexible, has provided us an unprecedented choice. Herein, an aptamer recognition method with high precise localization was developed for imaging membrane-bound N-acetylgalactosamine (GalNAc). By using direct stochastic optical reconstruction microscopy (dSTORM), we compared this aptamer recognition method with the lectin recognition method for visualizing the detailed structure of GalNAc at the nanometer scale. The results indicated that GalNAc forms irregular clusters on the cell membrane with a resolution of 23 ± 7 nm by aptamer recognition. Additionally, when treated with N-acetylgalactosidase, the aptamer-recognized GalNAc shows a more significant decrease in cluster size and localization density, thus verifying better specificity of aptamers than lectins. Collectively, our study suggests that aptamers can act as perfect substitutes for lectins in carbohydrate labeling, which will be of great potential value in the field of super-resolution fluorescence imaging.

Glycan-based diagnostic devices: current progress, challenges and perspectives

The development of glycan-based diagnostic devices is illustrated with recent examples from both carbohydrate recognition and device design aspects.